Both the nasal and IV forms of bumetanide had a variability in absorption of 27%, suggesting a more stable route of dosing ...

We know that exercise is good for our hearts and overall health. But is that true for people living with heart failure? And ...

agonists in heart failure and chronic kidney disease (CKD) patients was discussed. GLP-1R agonists are cardioprotective in ...

Sitting for over 10 hours or more a day is significantly linked to future heart failure and cardiovascular death risk, a new ...

Twin sisters living with heart failure are calling for an end to what they say is a postcode lottery when it comes to ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...

The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors in US patients hospitalized with heart failure (HF) and a left ...

New research highlights how air pollution exacerbates heart failure, revealing increased inflammation and the need for ...

Valuable data can successfully be collected with the noninvasive wearable, which is worn on the sternum, report investigators ...

Heart failure sounds scary - because it is. But here's the thing: millions of Americans are walking around right now with a ...

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking ...

The existing oral and intravenous forms of bumetanide are commonly prescribed for people with heart failure because they ease tissue swelling, a common cause of symptoms for people with heart failure.